Viewing Study NCT02549469


Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2025-12-25 @ 8:34 PM
Study NCT ID: NCT02549469
Status: COMPLETED
Last Update Posted: 2015-09-15
First Post: 2015-08-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bioequivalence of Single Dose Extended Release Naproxen Sodium (660 mg) Tablet Versus Naproxen Sodium (220 mg) Tablet Three Times Daily
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module